Anti-BTNL2 antibody [EPR12252]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal BTNL2 antibody. Suitable for WB and reacts with Human samples.
View Alternative Names
Butyrophilin-like protein 2, BTL-II, BTNL2
- WB
Supplier Data
Western blot - Anti-BTNL2 antibody [EPR12252] (AB181198)
All lanes:
Western blot - Anti-BTNL2 antibody [EPR12252] (ab181198) at 1/2000 dilution
Lane 1:
Human spleen tissue lysate at 20 µg
Lane 2:
Human tonsil tissue lysate at 20 µg
Lane 3:
Human small intestine tissue lysate at 20 µg
Lane 4:
K562 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab136636'>ab136636</a>) at 1/500 dilution
Predicted band size: 50 kDa
false
Related conjugates and formulations (1)
-
Anti-BTNL2 antibody [EPR12252] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
BTNL2 plays a significant role in modulating immune responses. It forms part of a complex with other immune checkpoint molecules providing inhibitory signals to T cells. This interaction helps maintain immune system balance and prevents excessive immune responses. The presence of BTNL2 in epithelial tissues suggests its involvement in mucosal immunity and interaction with the gut’s microbiome.
Pathways
BTNL2 directly participates in the immune checkpoint pathway. It negatively regulates the T-cell receptor signaling pathway in concert with proteins such as CTLA-4 and PD-1. These pathways are critical for maintaining immune homeostasis and avoiding autoimmunity by controlling T-cell activity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com